Association between Ophthalmic Timolol and Hospitalisation for Bradycardia

Introduction. Ophthalmic timolol, a topical nonselective beta-blocker, has the potential to be absorbed systemically which may cause adverse cardiovascular effects. This study was conducted to determine whether initiation of ophthalmic timolol was associated with an increased risk of hospitalisation...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratt, Nicole L., Ramsay, Emmae N., Kalisch Ellett, Lisa M., Nguyen, Tuan A., Roughead, Elizabeth E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385589/
https://www.ncbi.nlm.nih.gov/pubmed/25874117
http://dx.doi.org/10.1155/2015/567387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385589/
https://www.ncbi.nlm.nih.gov/pubmed/25874117
http://dx.doi.org/10.1155/2015/567387

Ejemplares similares